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Abstract: Two new pentaketides, including a new benzofuran-1-one derivative (1) and a new
isochromen-1-one (5), and seven new benzoic acid derivatives, including two new benzopyran
derivatives (2a, b), a new benzoxepine derivative (3), two new chromen-4-one derivatives (4b, 7)
and two new benzofuran derivatives (6a, b), were isolated, together with the previously reported
2,3-dihydro-6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one (4a), from the culture of the marine
sponge-associated fungus Neosartorya quadricincta KUFA 0081. The structures of the new compounds
were established based on 1D and 2D NMR spectral analysis, and in the case of compounds 1, 2a, 4b,
5, 6a and 7, the absolute configurations of their stereogenic carbons were determined by an X-ray
crystallographic analysis. None of the isolated compounds were active in the tests for antibacterial
activity against Gram-positive and Gram-negative bacteria, as well as multidrug-resistant isolates
from the environment (MIC > 256 µg/mL), antifungal activity against yeast (Candida albicans ATTC
10231), filamentous fungus (Aspergillus fumigatus ATTC 46645) and dermatophyte (Trichophyton
rubrum FF5) (MIC > 512 µg/mL) and in vitro growth inhibitory activity against the MCF-7
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and A375-C5 (melanoma) cell
lines (GI50 > 150 µM) by the protein binding dye SRB method.
Keywords: Neosartorya quadricincta KUFA 0081; marine-derived fungus; polyketides; pentaketides;
benzoic acid derivatives; Clathria reinwardti
1. Introduction
Aspergillus section Fumigati and its teleomorph Neosartorya include many important species
because they can be pathogenic or allergenic to man, as well as causing food spoilage and producing
mycotoxins. Certain species are also found to produce interesting bioactive secondary metabolites
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that can be considered to have potential for drug development [1]. For this reason, we have
investigated the bioactive secondary metabolites produced from the cultures of four Neosartorya
species collected from soil in Thailand, i.e., Neosartorya glabra KUFC 6311 [2], N. pseudofischeri KUFC
6422 [3], N. siamensis KUFC 6349 [4] and N. fischeri KUFC 6344 [5], as well as six marine-derived
species of Neosartorya, including N. paulistensis KUFC 7898 [6], N. laciniosa KUFC 7896 [5], N. spinosa
KUFC 8104, N. tsunodae KUFC 9213 [5], N. siamensis KUFA 0017 and N. takakii KUFC 7898 [7],
as well as one marine-derived Aspergillus species (Aspergillus similanensis KUFA 0013) [8,9]. Recently,
we have also reported the antifungal activity of the crude extract of N. quadricincta KUFA 0064,
isolated from an agricultural soil in Southern Thailand, against plant pathogenic fungi, which are
causative agents of diseases of economically-important plants of Thailand [10]. So far, the only
report on secondary metabolites of N. quadricincta was by Ozoe et al., who described the isolation of
dihydroisocoumarin derivative, PF1223, from the culture of N. quadricincta strain PF1223 (unidentified
source). This compound was shown to inhibit the [3H] EBOB binding by 65% [11]. Thus, in our
ongoing search for bioactive secondary metabolites from marine-derived fungi from Thai waters,
we have investigated the culture of N. quadricincta KUFA 0081, isolated from the marine sponge
Clathria reinwardti, which was collected from the Coral reef at Samae San Island in the Gulf of Thailand.
The ethyl acetate extract of the culture of this fungus yielded, besides the previously described
2,3-dihydro-6-hydroxy-2,2-dimethyl-4H-1-benzopyran-4-one (4a) [12], two new polyketide derivatives
(1, 5) and seven new benzoic acid derivatives (2a, 2b, 3, 4b, 6a, 6b and 7) (Figure 1). All of the isolated
compounds were tested for their antibacterial activity against Gram-positive and Gram-negative
bacteria, as well as multidrug-resistant isolates from the environment and for their antifungal activity
against yeast (Candida albicans ATCC 10231), filamentous fungus (Aspergillus fumigatus ATCC 46645)
and dermatophyte (Trichophyton rubrum FF5). Additionally, these compounds were also evaluated
for their in vitro growth inhibitory activity against the MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung cancer) and A375-C5 (melanoma) cell lines by the protein binding dye SRB method.
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Figure 1. Secondary metabolites of N. quadricincta KUFA0081. 
2. Results and Discussion 
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was established on the basis of the (+)-HRESIMS m/z 267.1243 [M + H]+ (calculated 267.1332), 
indicating six degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl (3455 
cm−1), conjugated ester carbonyl (1723 cm−1) and aromatic (1612, 1596 cm−1) groups. The 13C NMR, 
DEPT and HSQC spectra (Table 1, Supplementary Information, Figures S2 and S4) exhibited the 
signals of one conjugated ester carbonyl (δC 168.2), five quaternary sp2 (δC 164.6, 158.3, 152.8, 111.7, 
105.5), one methine sp2 (δC 94.5), one oxygen bearing quaternary sp3 (δC 88.8), one oxygen bearing 
methine sp3 (δC 70.8), two methoxyl (δC 56.1 and 56.0) and three methyl (δC 21.5, 17.8 and 11.2) groups. 
The 1H NMR spectrum (Table 1, Supplementary Information, Figure S1) revealed the presence of, 
besides a singlet of one aromatic proton at δH 6.41, a quartet of the oxymethine proton at δH 4.22 (J = 
6.4 Hz), two singlets of the methoxyl groups at δH 3.97 s and 3.92 s, two methyl singlets at δH 2.12 s 
and 1.76 s, a methyl doublet at δH 0.87 (J = 6.4 Hz) and a broad band of the hydroxyl proton at δH 2.15. 
The 1H and 13C data (Table 1) revealed the presence of a pentasubstituted benzene ring. That this 
pentasubstituted benzene ring was part of the 5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one 
ring system was corroborated by the HMBC correlations (Table 1, Figure 2a, Supplementary 
Information, Figure S5) of H-6 (δH 6.41, s) to C-7a (δC 105.3), C-4 (δC 111.7), C-7 (δC 158.3), C-5 (δC 
164.6) and C-1 (δC 168.2), of OMe-5 (δH 3.92, s) to C-5, of OMe-7 (δH 3.97, s) to C-7, of H3-8 (δH 2.12, s) 
to C-4, C-3a (δC 152.8) and C-5, of H3-9 (δH 1.76, s) to C-3a and of the NOESY correlations of H-6 to 
OMe-5 and OMe-7. That another substituent of C-3 was a 1-hydroxyethyl group was supported by 
the COSY correlations of H-10 (δH 4.22, q, J = 6.4 Hz) to H3-11 (δH 0.87, d, J = 6.4 Hz), by the HMBC 
correlations of H3-9 to C-10 (δC 70.8), C-3 (δC 88.8) and C-3a and of H3-11 (δH 0.87, d, J = 6.4 Hz) to C-
3 and C-10 (Table 1, Figure 2a), as well as by the NOESY correlations of H3-8 to H-10, H3-9, of H3-11 
to H-10, OH-10 and of H3-9 to H-10 (Table 1, Figure 2b, Supplementary Information, Figure S6). Final 
proof of the structure and the stereochemistry assigned to compound 1 was provided by its X-ray 
analysis (Figure 3), and since the diffraction data were collected with a Gemini PX Ultra equipped 
with CuKα radiation, it was possible to establish the absolute configurations of C-3 and C-10, 
respectively, as 3R and 10S. Since 1 is a new compound, we have named it quadricinctone A. 
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2. Results and Discussion
Compoun 1 was isol ted as white crystals (mp, 176–1 7 ˝C), and its molecular formula C14H18O5
was es abli he on the basis of the (+)-HRESIMS m/z 267.1243 [M + H]+ (calculated 267.1332), indicating
six degrees of unsatu ation. The IR spectrum showed absorption bands for hydroxyl (3455 cm´1),
conjug te ester carbonyl (1723 cm´1) and aromatic (1612, 1596 cm´1) groups. The 13C NMR, DEPT
and HSQC spectra (Table 1, Supplementary Information, Figures S2 and S ) exhibited the signals of
one conjugated ester carbonyl (δC 168.2), five quaternary sp2 (δC 164.6, 158.3, 152.8, 111.7, 105.5), one
ethine sp2 (δC 94.5), one oxygen bearing quaternary sp3 (δC 88.8), one oxygen bearing methine sp3
(δC 70.8), two methoxyl (δC 56.1 and 56.0) and three methyl (δC 21.5, 17.8 and 11.2) groups. The 1H NMR
spectrum (Table 1, Supplementary Information, Figure S1) revealed the presence of, besides a singlet
of one aromatic proton at δH 6.41, a quartet of the oxymethine proton at δH 4.22 (J = 6.4 Hz), two
singlets of the methoxyl groups at δH 3.97 s and 3.92 s, two methyl singlets at δH 2.12 s and 1.76 s,
a methyl doublet at δH 0.87 (J = 6.4 Hz) and a broad band of the hydroxyl proton at δH 2.15. The 1H and
13C data (Table 1) revealed the presence of a pentasubstituted benzene ring. That this pentasubstituted
benzene ring was part of the 5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one ring system was
corroborated by the HMBC correlations (Table 1, Figure 2a, Supplementary Information, Figure S5)
of H-6 (δH 6.41, s) to C-7a (δC 105.3), C-4 (δC 111.7), C-7 (δC 158.3), C-5 (δC 164.6) and C-1 (δC 168.2),
of OMe-5 (δH 3.92, s) to C-5, of OMe-7 (δH 3.97, s) to C-7, of H3-8 (δH 2.12, s) to C-4, C-3a (δC 152.8)
and C-5, of H3-9 (δH 1.76, s) to C-3a and of the NOESY correlations of H-6 to OMe-5 and OMe-7. That
another substituent f C-3 was a 1-hydroxyethyl group was supported by the COSY correlations of
H-10 (δH 4.22, q, J = 6.4 Hz) to H3-11 (δH 0.87, d, J = 6.4 Hz), by the MBC correlations of H3-9 to
C-10 (δC 70.8), C-3 (δC 88.8) and C-3a and of H3-11 (δH 0.87, d, J = 6.4 Hz) o C-3 and C-10 (T ble 1,
Figure 2a), as well as by the NOESY orrela ions of H3-8 to H-10, H3-9, of H3-11 to H-10, OH-10 and of
H3-9 to H-10 (Table 1, Figur 2b, Supplement ry Information, Figure S6). Fi al proof of the structure
and the stereochemistry assigned to compound 1 was provided by its X-ray analysis (Figure 3), and
since the diffraction data were collected with a Gemini PX Ultra equipped with CuKα radiation, it was
possible to establish the absolute configurations of C-3 and C-10, respectively, as 3R and 10S. Since 1 is
a new compound, we have named it quadricinctone A.
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Table 1. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz), HMBC and NOESY assignments for 1.
Position δC, type δH, (J in Hz) HMBC NOESY
1 168.2, CO -
3 88.8, C -
3a 152.8, C -
4 111.7, C -
5 164.6, C -
6 94.5, CH 6.41, s C-1, 4, 5, 7, 7a OMe-5, 7
7 158.3, C -
7a 105.3, C -
8 11.2, CH3 2.12, s C-3a, 4, 5, 7 H-9, 10
9 21.5, CH3 1.76, s C-3, 3a, 10 H-8, 9
10 70.8, CH 4.22, d (6.4) C-11 H-8, 9, 10
11 17.8, CH3 0.87, d (6.4) C-3, 10 H-10
OMe-5 56.1, CH3 3.92, s C-5 H-6
OMe-7 56.0, CH3 3.97, s C-7 H-6
OH-10 - 2.15, br - H-11
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Compound 2a was also isolated as white crystals (mp. 147–148 ˝C), and its molecular formula
C12H12O4 was determined based on the (+)-HRESIMS m/z 221.0820 [M + H]+ (calculated 221.0814),
indicating seven degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3447 cm´1), a conjugated carbonyl (1696 cm´1), aromatic (1609 cm´1) and olefin (1647 cm´1) groups.
The 13C NMR, DEPT and HSQC spectra (Table 2, Supplementary Information, Figures S8 and S10)
exhibited the signals of one conjugated carboxyl carbonyl (δC 167.0), three quaternary sp2 (δC 156.8,
123.0, 120.5), five methine sp2 (δC 130.8, 128.6, 127.9, 122.8, 115.7), one oxy-quaternary sp3 (δC 80.5),
one oxymethylene sp3 (δC 67.1) and one methyl (δC 23.3) groups. The 1H NMR spectrum (Table 2,
Supplementary Information, Figures S7) revealed, besides the presence of three aromatic protons
of the 1,2,4 trisubstituted benzene ring at δH 6.79, d (J = 8.4 Hz), 7.65, d (J = 2.1 Hz) and 7.69, dd
(J = 8.4, 2.1 Hz), two doublets of the protons of a cis-double bond at δH 6.56, d (J = 10.0 Hz) and 5.74,
d (J = 10.0 Hz), a methyl singlet at δH 1.31, a singlet of two protons at δH 3.46 and two broad signals
of the hydroxyl protons at δH 12.59 and 5.07, respectively. The COSY spectrum (Table 2, Figure 4a,
Supplementary Information, Figures S9) exhibited cross-peaks of H-4 (δH 6.56, d, J = 10.0 Hz) to
H-3 (δH 5.74, d, J = 10.0 Hz), of H-7 (δH 7.69, dd, J = 8.4, 2.1 Hz) to H-5 (δH 7.65, d, J = 2.1 Hz) and
H-8 (δH 6.79, d, J = 8.4 Hz), confirming the presence of the 1,2,4 trisubstituted benzene ring and
the cis-double bond. That the 1,2,4-trisubsituted benzene ring and the cis-double bond were part of
the 2H-chromene-6-carboxylic acid moiety was corroborated by the HMBC correlations (Figure 4a,
Supplementary Information, Figures S11) of H-5 to C-4 (δC 122.8), C-7 (δC 130.8), C-8a (δC 156.8) and
C-11 (δC 167.0), of H-7 to C-5 (δC 127.9), C-8a, C-11, of H-8 to C-4a (δC 120.5), C-6 (δC 123.0) and C-8a,
as well as of H-3 to C-4a and of H-4 to C-4a, C-5 and C-8a. As the HMBC spectrum also exhibited
correlations of the methyl singlet at δH 1.31 (H3-9) to C-3, C-2 (δC 80.5) and C-10 (δC 67.1) and of the
singlet at δH 3.46 (H-10) to C-2, C-3 and CH3-9 (δC 23.3), the methyl and hydroxymethyl groups were
placed on C-2. The NOESY correlations (Figure 4b, Supplementary Information, Figures S12) of H-4 to
H-3 and H-5, of H-3 to H-4, H3-9 and H2-10, of H-8 to H-7, H2-10 and H3-9 and of H3-9 to H-8, H-10
also confirmed this hypothesis. Since compound 2a was obtained in a suitable crystal, X-ray analysis
was carried out, and the ORTEP view shown in Figure 5 revealed that the absolute configuration of
C-2 is S. A literature search indicated that 2a has never been previously reported; therefore, it was
named quadricinctapyran A.
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Table 2. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) for 2a and 2b.
Position
2a 2b
δC, type δH, (J in Hz) COSY HMBC δC, type δH, (J in Hz) COSY HMBC
2 80.5, C - 78.5, C -
3 128.6, CH 5.74, d (10.0) H-4 C-2, 4a, 5, 9, 10 126.2, CH 5.59, d (10.0) H-4 C-2, 4a, 10
4 122.8, CH 6.56, d (10.0) H-3 C-2, 5, 8a 124.3, CH 6.51, d (10.0) H-3 C-2, 5, 8a
4a 120.5, C - 120.2, C -
5 127.9, CH 7.65, d (2.1) H-7 C-4, 8a, 11 128.9, CH 7.75, d (2.1) H-7 C-4, 7, 8a, 11
6 123.0, C - 122.0, C -
7 139.8, CH 7.69, dd (8.4, 2.1) H-5, 8 C-5, 8a, 11 132.2, CH 7.90, dd (8.5, 2.1) H-5, 8 C-5, 8a, 11
8 115.7, CH 6.79, d (8.4) H-7 C-4a, 6, 8a 116.1, CH 6.83, d (8.5) H-7 C-4a, 6, 8a
8a 156.8, C - 157.8, C -
9 23.3, CH3 1.31, s - C-2, 3, 10 24.0, CH3 1.48, s - C-2, 3, 10
10 67.1, CH2 3.45, s - C-2, 3, 9 68.8, CH2 4.13, d (11.7) H-10 C-2, 3, 9
4.24, d (11.7) H-10 C-2, 3, 9
11 167.0, CO - 171.7, CO -
OH-10 - 5.07, br - - -
OH-11 - 12.59, br - - 12.79, br -
OAc - 170.8, CO -
20.7, CH3 1.98, s - CO (Ac)
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Compound 2b was isolated as a white solid (mp. 118–119 ˝C), and its molecular formula C14H14O5
was established on the basis of the (+)-HRESIMS m/z 263.0971 [M + H]+ (calculated 263.0919), indicating
eight degrees of unsaturation. The 1H and 13C NMR spectral features (Supplementary Information,
Figures S13 and S14) of compound 2b resembled those of compound 2a, except for an additional
carbonyl carbon at δC 170.8 and a methyl group at δC 20.7 (δH 1.98, s), characteristic of the acetoxyl
group (Table 2). Moreover, since the signals of the oxymethylene protons (H2-10) of compound 2b
appeared as two doublets at δH 4.13 (J = 11.7 Hz) and 4.24 (J = 11.7 Hz), ca. 0.7 ppm higher than that of
H2-10 in compound 2a, it was clear that the acetoxyl group was on C-10. This was also corroborated by
the HMBC correlations (Table 2, Figure 6a, Supplementary Information, Figure S17) of H2-10 and the
methyl singlet at δH 1.98 to the carbonyl of the acetoxyl group (δC 170.8). Since Compound 2b could
not be obtained as a suitable crystal for X-ray analysis, the absolute configuration of its C-3 could not
be determined with certainty. However, as compound 2b is the acetate derivative of compound 2a,
it was speculated that the stereochemistry of its C-2 should be the same as that of C-2 of compound 2a,
i.e., 2S. In order to confirm this hypothesis, the NOESY experiments were carried out. The NOESY
spectrum of compound 2b showed a weak correlation of H-8 to H3-9 and not to H2-10 (Figure 6b,
Supplementary Information, Figure S18), similar to what has been observed for compound 2a. Acid
hydrolysis of 2b gave the product whose structure was confirmed as 2a by 1H and 13C NMR data,
as well as the optical rotation. Therefore, the absolute configuration of C-2 of 2b is assigned as 2S.
Compound 2b is also a new compound, thus we named it quadricinctapyran B.
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The molecular formula C12H12O4 of compound 3, a white solid (mp 189–191 ˝C), was established
based on the (+)-HRESIMS m/z 221.0819 [M + H]+ (calculated 221.0814), and thus, it is an isomer of
compound 2a. Furthermore, the general features of its 1H and 13C NMR spectra resembled those of
compound 2a. However, the chemical shift values of some of the proton and carbon signals were
slightly different from those observed in compound 2a. The 13C NMR, DEPT and HSQC spectra
(Table 3, Supplementary Information, Figures S20 and S22) exhibited the signals of one conjugated
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carboxyl carbonyl (δC 166.7), three quaternary sp2 (δC 161.2, 125.3, 125.0), five methine sp2 (δC 139.5,
134.6, 129.8, 123.5, 119.8), one oxy-quaternary sp3 (δC 70.7), one oxymethylene sp3 (δC 77.0) and one
methyl (δC 26.1) groups. The 1H NMR spectrum (Table 3, Supplementary Information, Figure S19)
revealed the existence of three aromatic protons of the 1,2,4-trisubstituted benzene ring, similar to
that of compound 2a, at δH 7.05, d (J = 8.4 Hz), 7.74, dd (J = 8.4, 2.1 Hz), 7.89, d (J = 2.1 Hz), two
olefinic protons of the cis-double bond at δH 5.95, dd (J = 12.0, 1.2 Hz) and 6.31, d (J = 12.0 Hz), two
oxymethylene protons at δH 3.84, d (J = 11.1 Hz) and 4.02, dd (J = 11.1, 1.6 Hz), and a methyl singlet
at δH 1.26. That the carboxylic acid functionality was on C-7, and the substituent with a cis-double
bond was on C-5a was substantiated by the HMBC correlations of H-6 (7.89, d, J = 2.1 Hz) to C-10
(δC 166.7), C-9a (δC 161.2), C-8 (δC 129.8) and C-5 (δC 123.5), of H-5 (δH 6.31, d, J = 12.0 Hz) to C-6
(δC 134.5) and C-9a and of H-4 (δH 5.95, dd, d, J = 12.0, 1.2 Hz) to C-5a (δC 125.0) (Table 3 and Figure 7a,
Supplementary Information, Figure S23). However, contrary to compound 2a, compound 3 showed
the HMBC correlations of H2-2 (δH 3.84, d, J = 11.1 Hz and 4.02, dd, J = 11.1, 1.6 Hz) to not only
C-4 (δC 139.5), but also to C-9a (Table 3 and Figure 7a). Consequently, the benzoic acid moiety was
fused with the 2,3,6,7-tetrahydro-oxepine ring through C-5a and C-9a. That the methyl group and the
hydroxyl group were on C-3 of the oxepin ring was confirmed by the HMBC correlations of the methyl
singlet at δH 1.26 (H-11) to C-3 (δC 70.7), C-2 (δC 77.0) and C-4, as well as of H2-2 to C-11 (δC 26.1) and
C-3 (Table 3 and Figure 7). This was also corroborated by the NOESY correlations of H3-11 to OH-3
(δH 3.39, br), H2-2 and H-4 (Table 3 and Figure 7b, Supplementary Information, Figure S24). Therefore,
Compound 3 was identified as 3-hydroxy-3-methyl-2,3-dihydro-1-benzoxepine-7-carboxylic acid.
Table 3. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 3.
Position δC, type δH, (J in Hz) COSY HMBC NOESY
2α 77.0, CH2 3.84, d (11.1) H-2β C-3, 4, 9a, 11 H-2β, 4 (w), 11 (w)
β 4.02, dd (11.1, 1.6) H-2α C-3, 4, 9a, 11 H-2α, 4 (w), 11 (str)
3 70.7, C -
4 139.5, CH 5.95, dd (12.0, 1.2) H-5 C-2, 5a H-2α (w), 5, 9 (w), 11
5 123.5, CH 6.31, d (12.0) H-4 C-3, 5a, 6, 9a H-4, 6 (str)
5a 125.0, C -
6 134.5, CH 7.89, d (2.1) H-8 C-5, 8, 9a, 10 H-5
7 125.3, C -
8 129.8, CH 7.74, dd (8.4, 2.1) H-6, 9 C-6, 9a H-9
9 119.8, CH 7.05, d (8.4) H-8 C-5a, 7, 9a H-8
9a 161.2, C -
10 166.7, C -
11 26.1, CH3 1.26, s - C-2, 3, 4 H-2α (w), 2β (str)
OH-3 - 3.39, br - H-4, 11
COOH - 12.79, br -
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theory used (MP2/6-311G, PM3, MMFF and MM2). All methods, except for PM3, also agree that 
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However, this difference can be attributed to a weak intramolecular hydrogen bond in conformation 
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methods, and assigns virtually the same energy to both conformations of 3, while still orienting  
HO-3 towards the seven-membered ring. Since DMSO solvent molecules compete for HO-3 hydrogen 
a) b)
11
7 7
8 8
99
1111 66 1010
4 4
33
22
9a9a
5a5a
5 5
Figure 7. Key COSY (–), HMBC (Ñ) (a) and NOESY (Ø) (b) correlations for compound 3.
Mar. Drugs 2016, 14, 134 9 of 26
As compound 3 could not be obtained as a suitable crystal for X-ray analysis, an effort to
tentatively determine the relative configuration of the stereogenic carbon (C-3) by molecular mechanics
conformation analysis and the NOESY experiments was carried out. Stochastic conformational search
on the computational models of the structure of 3 with C-3 in R configuration, followed by energy
minimization, converged to two half-chair conformations for the seven-membered ring C1 and C2, as
depicted in Figure 8, regardless of the modelling level of the theory used (MP2/6-311G, PM3, MMFF
and MM2). All methods, except for PM3, also agree that conformation C2, with the methyl group in
the equatorial position, is more stable by ca. 2 kcal/mol. However, this difference can be attributed to a
weak intramolecular hydrogen bond in conformation C2, between HO-3 and O-1, which is not possible
in conformation C1. The semi-empirical PM3 method gives less weight to non-ideal intramolecular
hydrogen bonds, as compared to the other methods, and assigns virtually the same energy to both
conformations of 3, while still orienting HO-3 towards the seven-membered ring. Since DMSO solvent
molecules compete for HO-3 hydrogen bonding, it is more likely that the intramolecular bond is not an
important feature of ring conformation C2 and that, in reality, both conformations have approximately
the same energy.
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The average effective positions of the three methyl H-11i protons are relative to H-2a or H-2b. 
The predicted ratio reff (H-2a/H-11)/reff (H-2b/H-11) is 1.40 (1.36, if r−3 averages are used instead of r−6). 
Assuming that the cross-relaxation rate is similar in both cases, the NOE intensities should also have 
a similar ratio [14]. Since the observed intensities ratio is actually closer to two, the evidence points 
towards the predominance of the conformation C1. Since, as stated previously, both conformations 
have similar conformational energy, the higher stability of 3R-C1 of 3 (or of its stereoisomer 3S-C2) 
must originate from the ready interaction of the equatorial HO-3 with the hydrogen-bonding solvent 
and also from a higher entropic rotational freedom of the hydroxyl and methyl groups. The NOESY 
spectrum also revealed the correlations of both H2-2 to H-9. However, only one of the H2-2, i.e., the 
doublet at δH 3.84 (J = 11.1 Hz), showed a weak cross-peak to H-4, while the double doublet at δH 4.02 
(J = 11.1, 1.6 Hz) did not give any cross-peak to H-4. This observation led to the conclusion that the 
plucked oxepin ring should adopt the conformation in which H-2 at δH 3.84 is near H-4, i.e., in the α 
(axial), while H-2 at δH 4.02 is in β (equatorial) positions, which is in agreement with our 
Figure 8. The two minimal energy conformations, C1 and C2, for the structure of 3, with R configuration
for C-3. All calculated distances and energies are exactly the same for the pairs 3R-C1/3S-C2 and
3R-C2/3S-C1. The shorter predicted inter-hydrogen distances H-2/H-11 are presented; for a discussion
of the average, NOE effective distances, please refer to the main text.
Both model conformations of 3 predict hydrogen-hydrogen distances that are similar to within
0.2 Å, with the exception of some distances to the methyl group (H3-11). The most notable are to
the diastereotopic hydrogens (H2-2), partially presented in Figure 8. While both conformations show
almost the same distance between H-2a and H-11, a difference is predicted between H-2b and H-11
if the conformation C1 predominates, which should be apparent in the build-up rate of NOESY
cross-peaks for small mixing times. Alternatively, the predominance of the conformation C2 would
be indicated by two equal strength cross-peaks for H-2a and H-2b in cross-relaxation with H-11. It is
observed that the H-2b (δH 3.84, d, J = 11.1 Hz)/H-11 NOESY cross-peak is weak while the H-2a
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(δH 4.02, dd, J = 11.1, 1.6 Hz)/H-11 is medium, suggesting that the conformation C1 predominates.
NOE effective distances, reff, are calculated by [13] :
re f f “
˜
1
3
ÿ
i
r´6H´2{H´10i
¸´1{6
The average effective positions of the three methyl H-11i protons are relative to H-2a or H-2b.
The predicted ratio reff (H-2a/H-11)/reff (H-2b/H-11) is 1.40 (1.36, if r´3 averages are used instead of
r´6). Assuming that the cross-relaxation rate is similar in both cases, the NOE intensities should also
have a similar ratio [14]. Since the observed intensities ratio is actually closer to two, the evidence points
towards the predominance of the conformation C1. Since, as stated previously, both conformations
have similar conformational energy, the higher stability of 3R-C1 of 3 (or of its stereoisomer 3S-C2) must
originate from the ready interaction of the equatorial HO-3 with the hydrogen-bonding solvent and also
from a higher entropic rotational freedom of the hydroxyl and methyl groups. The NOESY spectrum
also revealed the correlations of both H2-2 to H-9. However, only one of the H2-2, i.e., the doublet at δH
3.84 (J = 11.1 Hz), showed a weak cross-peak to H-4, while the double doublet at δH 4.02 (J = 11.1, 1.6 Hz)
did not give any cross-peak to H-4. This observation led to the conclusion that the plucked oxepin ring
should adopt the conformation in which H-2 at δH 3.84 is near H-4, i.e., in the α (axial), while H-2 at δH
4.02 is in β (equatorial) positions, which is in agreement with our conformational analysis. A literature
search revealed that compound 3 is also a new compound, so we named it quadricinctoxepine.
Compound 4b was isolated as white crystals (mp, 227–228 ˝C), and its molecular formula
C12H14O4S was established on the basis of the (+)-HRESIMS m/z 255.0694 [M + H]+ (calculated
255.0691). The IR spectrum showed absorption bands for hydroxyl (3442 cm´1), conjugated ketone
carbonyl (1690 cm´1) and aromatic (1622 cm´1) groups. The 13C NMR, DEPT and HSQC spectra
(Table 4, Supplementary Information, Figures S26 and S28) exhibited the signals of one conjugated
ketone carbonyl (δC 191.2), four quaternary sp2 (δC 151.6, 147.4, 135.7, 120.8), two methine sp2 (δC 118.0,
112.4), one oxy-quaternary sp3 (δC 80.9), one methylene sp2 (δC 48.0) and three methyl (δC 40.8, 26.1
and 25.7) groups. The 1H NMR spectrum (Table 4, Supplementary Information, Figure S25) exhibited,
besides a broad singlet of the phenolic hydroxyl group at δH 9.85, the signals of two meta-coupled
aromatic protons at δH 7.17, d (J = 3.1 Hz) and δH 7.35, d (J = 3.1 Hz), two geminally-coupled methylene
protons at δH 2.80, d (J = 16.6 Hz) and 2.82, d (J = 16.6 Hz) and three methyl singlets at δH 1.38, s,
1.39, s, and 2.77, s. The chemical shift value of the methyl singlet at δH 2.77, s (δC 40.8), indicated
that it was on the electron-withdrawing moiety. That compound 4b was a 2,2,6,8-tetrasubstituted
2,3-dihydro-4H-chromen-4-one derivative was supported by the HMBC correlations of H-5 (δH 7.17, d,
J = 3.1 Hz) to C-4 (δC 191.2), C-7 (δC 118.0) and C-8a (δC 147.4), of H-7 (δH 7.35, d, J = 3.1 Hz) to C-5
(δC 112.4), C-8 (δC135.7), C-8a, as well as of H-2 (δH 2.80, d, J = 16.6 Hz and 2.82, d, J = 16.6 Hz) to C-3
(δC 80.9) and C-4 (Table 4, Figure 9, Supplementary Information, Figure S28). As the HMBC spectrum
also exhibited cross-peaks of a broad singlet of the phenolic hydroxyl proton at δH 9.85 to C-5, C-6
(δC 151.6) and C-7 and of the singlets of the methyl groups at δH 1.38 and 1.39 to C-2 (δC 48.0) and
C-3, the hydroxyl group was placed on C-6, and the two methyl groups were placed on C-2. Since
this partial structure accounted for only C11H11O3, another portion of the molecule must contain
CH3SO. That the methyl sulfoxide group was on C-8 was supported by the presence of the deshielded
methyl group at δH 2.77, s (δC 40.8), as well as by the HBMC cross-peak of H3-11 (δH 2.77, s) to C-8.
Final proof of the structure of compound 4b was provided by its X-ray analysis, and its ORTEP view
is shown in Figure 10. Moreover, the ORTEP view also revealed that the absolute configuration of
the sulfoxide group in compound 4b is R. A literature search showed that compound 4b is a new
compound, and thus, we have named it quadricinctone B.
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Table 4. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 4b.
Position δC, type δH, (J in Hz) COSY HMBC
2 80.9, C -
3 48.0, CH2 2.80, d (16.6) H-3 C-2, 4, 9, 10
2.85, d (16.6) H-3 C-2, 4, 9, 10
4 191.2, CO -
4a 120.8, C -
5 112.4, CH 7.17, d (3.1) H-7 C-4, 6, 7, 8a
6 151.6, C -
7 118.7, CH 7.35, d (3.1) H-5 C-5, 6, 8, 8a
8 135.7, C -
8a 147.4, C -
9 26.1, CH3 1.39, s - C-2, 3, 10
10 25.7, CH3 1.38, s - C-2, 3, 9
11 40.8, CH3 2.77, s - C-8
OH-6 - 9.85, s C-5, 6, 7Mar. Drugs 2016, 14, 134 12 of 29 
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The molecular formula C12H14O6 of compound 5 was determined based on the (+)-HRESIMS
m/z 255.0875 (calculated 255.0869), indicating six degrees of unsaturation. The IR spectrum exhibited
absorption bands for hydroxyl (3439 cm´1), conjugated ester carbonyl (1660 cm´1) and aromatic
(1643 cm´1) groups. The 13C NMR, DEPT and HSQC spectra (Table 5, Supplementary Information,
Figures S31 and S33) exhibited the signals of one conjugated ester carbonyl (δC 168.8), five quaternary
sp2 (δC 162.9, 161.3, 144.6, 113.5, 98.9), one methine sp2 (δC 99.9), one quaternary sp3 of a hemiketal
(δC 104.8), one methine sp3 (δC 34.9), one oxymethylene sp3 (δC 63.7) and two methyl (δC 16.3 and 9.8)
carbons. The 1H NMR spectrum (Table 5, Supplementary Information, Figure S30) exhibited, besides a
singlet of one aromatic proton at δH 6.27, a singlet of a hydrogen-bonded phenolic hydroxyl at δH 11.24
and a broad signal of another phenolic hydroxyl at δH 10.62, two broad signals of the hydroxyl groups
at δH 5.26 and 7.07, one broad doublet of two methylene protons at δH 3.65 (J = 16.6 Hz), a broad signal
of one methine proton at δH 3.26, one methyl doublet at δH 1.06 (J = 7.2 Hz) and one methyl singlet at
δH 1.98. That compound 5 was a 3,3,4,5,6,8-hexasubstituted 3,4-dihydro-1H-isochromen-1-one was
supported by the HBMC correlations of OH-8 (δH 11.24, s) to C-8 (δC 161.3), C-7 (δC 99.9), C-8a (δC 98.9)
and of H-7 (δH 6.27, s) to C-5 (δC 113.5), C-6 (δC 162.9), C-8 and C-8a (Table 5, Figure 11, Supplementary
Information, Figure S34). Since the methyl singlet at δH 1.98 gave HMBC cross-peaks to C-5 and the
carbons at δC 144.6 and 162.9 (Table 5, Figure 11), the methyl group (δH 1.98; δC 9.8) and another
hydroxyl group (δH 10.62, br) were placed on C-5 and C-6, respectively, and the carbon signals at δC
144.6 and 162.9 were assigned for C-4a and C-6, respectively. On the other hand, the COSY spectrum
(Table 5, Supplementary Information, Figure S32) showed cross-peaks of the broad signal at δH 3.26 to
the methyl doublet at δH 1.06 (J = 7.2 Hz) and of the broad signal at δH 5.26 to the broad doublet at
δH 3.65 (J = 16.6 Hz), while the HMBC spectrum (Table 5, Figure 11) gave cross-peaks of the methyl
doublet at δH 1.06 (J = 7.2 Hz) to C-4a, C-4 (δC 34.9), and the signal of the quaternary carbon at δC
104.8 (C-3), the methyl and the hydroxymethyl substituents were placed on C-4 and C-3, respectively.
Therefore, another hydroxyl group (δH 7.07, br) was on C-3. This was supported by the chemical shift
value of C-3, which is typical for a hemiketal carbon. Since compound 5 could be obtained as a suitable
crystal (mp. 223–224 ˝C), its X-ray analysis was performed. The ORTEP view of compound 5, shown in
Figure 12, not only confirmed the proposed structure, but also determined the absolute configuration
of C-3 and C-4 as 3S, 4R. Since compound 5 is a new compound, it was named quadricinctone C.
Table 5. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 5.
Position δC, type δH, (J in Hz) COSY HMBC
1 168.8, C -
3 104.8, C -
4 34.9, CH 3.26, m H3-10
4a 144.6, C -
5 113.5, C -
6 162.9, C -
7 99.9, CH 6.27, s - C-1 (w), 5, 6, 8, 8a
8 161.3, C -
8a 98.9, C -
9 63.7, CH2 3.65, brd (16.6) OH-9
10 16.3, CH3 1.06, d (7.2) H-4 C-3, 4, 4a
11 9.8, CH3 1.98, s - C-4a, 5, 6
OH-3 - 7.07, br -
OH-5 - 10.62, br -
OH-8 - 11.24, s - C-7, 8, 8a
OH-9 - 5.26, br -
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Compound 6a was also isolated as white crystals (mp. 149–150 ˝C), and its molecular formula
C12H14O4 was determined based on the (+)-HRESIMS m/z 223.9067 [M + H]+ (calculated 223.9070),
indicating six degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3417 cm´1), a conjugated carbonyl (1681 cm´1) and aromatic (1634 cm´1) groups. The 13C NMR,
DEPT and HSQC spectra (Table 6, Supplementary Information, Figures S36 and S38) exhibited the
signals of one conjugated carboxyl carbonyl (δC 167.2), two quaternary sp2 (δC 128.2, 122.6), one
oxy-quaternary sp2 (δC 163.7), three methine sp2 (δC 130.4, 126.4, 108.4), one oxy-quaternary sp3
(δC 70.0), one oxymethine sp3 (δC 90.2), one methylene sp2 (δC 29.3) and two methyl (δC 25.9 and
24.9) carbons. The 1H NMR spectrum (Table 6, Supplementary Information, Figure S35) showed
signals of three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 7.75, d (J = 1.8 Hz), 7.72,
dd (J = 8.3, 1.8 Hz), 6.80, d (J = 8.3 Hz), in addition to a broad signal of the hydroxyl proton at δH
12.49, a triplet of one proton at δH 4.64 (J = 8.9 Hz), a doublet of two protons at δH 3.17 (J = 8.9 Hz)
and two methyl singlets at δH 1.13 and 1.14. That the 1,2,4-trisubstituted benzene ring was part of
2,5-disubstituted 2,3-dihydro-1-benzofuran was supported by the COSY correlations of H-6 (δH 7.72,
dd, J = 8.3, 1.8 Hz) to H-4 (δH 7.75, d, J = 1.8 Hz) and H-7 (δH 6.80, d, J = 8.3 Hz) and of H-2 (δH 3.17,
J = 8.9 Hz) to H-3 (δH 4.64, J = 8.9 Hz)(Table 6, Figure 13a, Supplementary Information, Figure
S37), as well as of the HMBC correlations of H-4 to C-6 (δC 130.4) and C-7a (δC 163.7), of H-6 to
C-4 (δC 126.4), of H-3 to C-2 (δC 90.2), C-3a (δC 128.2) and C-7a and of H-7 to C-3a, C-7a and C-5
(δC 122.6) (Table 6, Figure 13a, Supplementary Information, Figure S39). That the carboxyl group
was on C-5 was supported by the HMBC correlations of H-4 and H-6 to the conjugated carbonyl
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at δC 167.2 (Table 6, Figure 13a), along with the presence of a broad signal at δH 12.49, which is
characteristic of a hydroxyl group of carboxylic acid. In the same manner, that the 2-hydroxypropyl
substituent was placed on C-2 was evidenced by the HMBC correlations of H-2 (δH 4.64, J = 8.9 Hz)
to C-3 (δC 29.3), C-11 (δC 70.0), C-21 (δC 24.9), C-31 (δC 25.9) (Table 6, Figure 13a), as well as by the
NOESY correlations of H-2 to H-3, H3-21 (δH 1.14, s) and H3-31 (δH 1.13, s)(Figure 13b). Therefore,
compound 6a was identified as 2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic
acid. A literature search revealed that compound 6a has the same flat structure as anodendroic
acid (2-(1-hydroxy-1-methylethyl)-2,3-dihydrobenzofuran-5-carboxylic acid), which was first isolated
from the stem of Anodendron affine Durce [15]. Anodendroic acid was later synthesized by
Yamaguchi et al. [16]; however, its 1H NMR data (DMSO-d6) were slightly different from those
reported by Shima et al. [15]. Anodendroic acid was also obtained by basic hydrolysis of
its methyl ester, a constituent of Eriodictyon sessilifolium [17], and also by biotransformation of
3-(γ,γ-dimethylallyl)-p-coumaric acid [18]. It is interesting to note that, in all of these reports, the
identity of anodendroic acid was achieved by comparing its melting point, 1H NMR and MS data
with those reported by Shima et al. [15], while no stereochemistry of C-2 was indicated. However,
when compared to the 1H NMR and other physical data of compound 6a with those reported for
anodendroic acid by Shima et al. [15], it was found that the 1H NMR data of anodendroic acid
(in pyridine-d6) [15] were slightly different from those of compound 6a (in DMSO-d6). Therefore,
it was not possible to compare these 1H NMR data, since they were obtained in different solvents.
Interestingly, the 1H NMR data, obtained in DMSO-d6 by Yamaguchi et al. [16], were also slightly
different from those of compound 6a. The obvious differences between anodendroic acid [15] and
compound 6a are their melting points and optical rotations. While anodendroic acid (mp. 212–214 ˝C)
is laevorotatory (rαs26D ´19˝, c 0.7, EtOH) [15], compound 6a (mp. 149–150 ˝C) is dextrorotatory
(rαs20D +74˝, c 0.03, MeOH). Consequently, we concluded that the structure of compound 6a is different
from that of anodendroic acid. This fact has prompted us to investigate the stereochemistry of
compound 6a. Since Compound 6a was obtained as a suitable crystal for X-ray diffraction, its X-ray
analysis was carried out. The ORTEP view of compound 6a shown in Figure 14 not only confirmed its
proposed structure, but also revealed the absolute configuration for C-2 as 2R. Therefore, compound
6a is a new compound, and we have named it quadricinctafuran A. Since anodendroic acid exhibited
the opposite sign of rotation to that of compound 6a, it is probable that the absolute configuration of
its C-2 is 2S. This is not unusual, since fomannoxin, another 2,3-dihydrobenzofuran derivative, also
showed the opposite optical rotation and has the opposite absolute configuration to tremetone, even
though they have very similar structures [16].Mar. Drugs 2016, 14, x FOR PEER REVIEW 18 of 29 
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Figure 13. Key COSY (–), HMBC (Ñ) (a) and NOESY (Ø) (b) correlations for compound 6a.
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Table 6. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 6a and 6b.
Position
6a 6b
δC, type δH, (J in Hz) COSY HMBC δC, type δH, (J in Hz) COSY HMBC
2 90.2, CH 4.64, t (8.9) H-3 C-11, 21, 31 86.5, CH 4.83, dd (9.7, 8.1) H-3
3 29.3, CH2 3.17, d (8.9) H-2 C-11, 2, 3a, 7a 28.7, CH2 3.19, m H-2 C-11, 3a
3a 128.2, C - 128.4, C -
4 126.4, CH 7.75, d (1.8) H-6 C-6, 7a, 8 126.4, CH 7.76, d (1.8) H-6 C-3, 6, 7a
5 122.6, C - 122.6, C -
6 130.4, CH 7.72, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8 130.8, CH 7.71, dd (8.3, 1.8) H-4, 7 C-4, 7a, 8
7 108.4, CH 6.80, d (8.3) H-6 C-3a, 5, 7a 108.4, CH 6.79, d (8.3) H-6 C-3a, 5, 7a
7a 163.7, C - 163.6, C -
8 167.2, C - 167.2, C -
11 70.0, C - 72.5, C -
21 24.9, CH3 1.14, s - C-11, 2, 31 66.7, CH2 3.33, s - C-11, 2, 31
31 25.9, CH3 1.13, s - C-11, 2, 21 20.0, CH3 1.09, s C-11, 2, 21
OH-8 - 12.49, br - - 12.47, br -
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Figure 14. ORTEP diagram of 6a.
The (+)-HRESIMS of compound 6b gave the [M + H]+ at m/z 239.0919 (calculated 239.0919),
indicating its molecular formula C12H14O5 and, therefore, six degrees of unsaturation. The general
features of its 1H and 13C NMR spectra resembled those f compou d 6a. The 13C NMR, DEPT and
HSQC spectra (Table 6, Supplementary Information, Figures S42 and S44) exhibited the signals of one
conjugated carboxyl carbonyl (δC 167.2), tw quaterna y sp2 (δC 128.4, 122.6), on oxy-quaternary sp2
(δC 163.6), three methine sp2 (δC 130.8, 126.4, 108.4), one oxy-quaternary sp3 (δC 72.5), one oxymethine
sp3 (δC 86.5), one m thylen sp2 (δC 28.7), one oxymethylene sp2 (δC 66.7) and one methyl (δC 20.0)
carbons. The 1H NMR and COSY spectra (Table 6, Supplementary Information, Figures S41 and S43)
showed similar proton signals of e 2,3-dihydro-1-benzofuran-5-carboxylic acid nu leus to those of 6a.
However, it exhibited only one methyl singlet at δH 1.09 and another singlet of oxymethylene protons
at δH 3.33, instead of two methyl singlets as in compound 6a. Therefore, the difference between the
structures of compounds 6a and 6b resides in the substitutions on C-2. That the substituent on C-2 of
compound 6b was 1,2- ihydroxypr pyl wa evidenced by not on y its molecular formula (C12H14O5),
which has one more oxygen atom than that of compound 6a (C12H14O4), but also the presence of the
oxymethylene carbon a δC 66.7 (C-21; δH 3.33, s). Moreove , th chemical shift value of C-2 (δC 86.5)
was nearly 4 ppm lower than that of compound 6a (δC 90.2). Thus, compound 6b was identified as
2-(1,2-dihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid. This was confirmed by the
HMBC correlations of H3-31 (δH 1.09) to C-11 (δC 72.5) and C-21 (δC 66.7), as well of H2-21 (δH 3.33, s) to
C-11 (δC 72.5) and C-31 (δC 20.0) (Figure 15, Supplementary Information, Figure S45). Since compound
6b could not be obtained as suitable crystals for X-ray crystallography, it was not possible to determine
the absolute configuration of C-2 by X-ray analysis. Moreover, as compound 6b also has a tertiary
hydroxyl group on C-11 and a primary hydroxyl group on C-21, it was not possible to determine the
absolute configurations of C-2 and C-11 by Mosher’s method. On the other hand, since the methyl
group on C-1 in compound 6a was replaced by the hydroxymethyl group incompound 6b, it is
legitimate to postulate that compounds 6b is derived from compound 6a. Consequently, the absolute
configuration of C-2 of compound 6b should be the same as that of compound 6a, i.e., 2R. However,
it is not yet possible to determine the absolute configuration of C-11. Compound 6b is also a new
compound, and we have named it quadricinctafuran B.
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Compound 7 was also isolated as white crystals (mp. 196–197 ˝C), and its molecular formula
C14H12O5 was established on the basis of the (+)-HRESIMS m/z 237.0792 [M + H]+ (calculated 237.0763),
indicating seven degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3404 cm´1), conjugated ketone carbonyl (1708 cm´1), conjugated carboxyl carbonyl (1670 cm´1) and
aromatic (1558, 1540 cm´1) groups. The 13C NMR, DEPT and HSQC spectra (Table 7, Supplementary
Information, Figures S48 and S50) exhibited the signals of one conjugated ketone carbonyl (δC 191.1),
one conjugated carboxyl carbonyl (δC 166.4), one oxy-quaternary sp2 (δC 162.9), two quaternary
sp2 (δC 123.0, 119.6), three methine sp2 (δC 136.4, 127.5, 118.5), one oxy-quaternary sp3 (δC 83.0),
one oxymethylene sp2 (δC 66.8), one methylene sp2 (δC 43.4) and one methyl (δC 21.2) carbons.
The 1H NMR spectra (Table 7, Supplementary Information, Figure S47) exhibited, besides the signals of
three aromatic protons of the 1,2,4-trisubstituted benzene ring at δH 8.26, d (J = 2.3 Hz), 8.04, dd (J = 8.7,
2.3 Hz), 7.07, d (J = 8.7 Hz), a methyl singlet at δH 1.30, two pairs of geminally-coupled methylene
protons at δH 2.74, d (J = 16.7 Hz)/3.00, d (J = 16.7 Hz) and δH 3.49, dd (J = 11.6, 4.5 Hz)/3.59, dd
(J = 11.6, 4.2 Hz); the latter showed COSY correlations with the broad triplet of the hydroxyl proton
at δH 5.26 (Table 7, Figure 16a, Supplementary Information, Figure S49). As the HMBC spectrum
exhibited correlations of the aromatic proton signal at δH 8.26, d (J = 2.3 Hz, H-5) to the oxy-quaternary
sp2 carbon at δC 162.9 (C-8a), as well as to the conjugated ketone carbonyl carbon at δC 191.1 (C-4)
and the methine sp2 at δC 136.4 (C-7) (Table 7, Figure 16a, Supplementary Information, Figure S51),
the ketone moiety was placed on C-4a. Additionally, the HMBC spectrum also showed correlations
of H-8 (δH 7.07, d, J = 8.7 Hz) to C-8a and the quaternary sp2 carbons at δC 123.0 and 119.6; they
were therefore assigned to C-4a and C-6, respectively (Table 7, Figure 16a). The presence of the
1-hydroxy-2-methyl-2-oxypropyl moiety was supported by the HMBC correlations of the methyl
singlet at δH 1.30 (CH3-9) to the oxy-quaternary sp3 carbon at δC 83.0 (C-2), the oxymethylene sp3
carbon at δC 66.8 (C-10) and the methylene sp3 carbon at δC 43.4 (C-3), as well as of the H2-3 (δH 2.74,
d, J = 16.7 Hz/3.00, d, J = 16.7 Hz) to C-2, C-9 (δC 21.2) and C-10 (Table 7, Figure 16a). Since H2-3
also gave a HMBC cross-peak to C-4, the 1-hydroxy-2-methyl-2-oxypropyl moiety was linked to
C-4. Due to the fact that these two moieties accounted for only C11H12O4, it was concluded that
the carboxyl group (δC 166.4, δH 12.69 br) was on C-6. Therefore, compound 7 was identified as
2-(hydroxymethyl)-2-methyl-4-oxo-3,4-dihydro-2H-chromene-6-carboxylic acid. As compound 7 was
obtained as a suitable crystal for an X-ray diffraction, its X-ray analysis was carried out. The ORTEP
view of compound 7, shown in Figure 17, revealed the absolute configuration for C-2 as 2S. A literature
search revealed that compound 7 is also a new compound, so we named it quadricinctone D.
Table 7. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.47 MHz) and HMBC assignment for 7.
Position δC, Type δH, (J in Hz) COSY HMBC NOESY
2 80.3, C -
3α 434, CH2 2.74, d (16.7) H-3 C-2, 4, 10, 11 H3-11 (str)
β 3.00, d (16.7) H-3 C-2, 4, 10, 11 H3-11 (w)
4 191.1, CO -
4a 123.0, C -
5 127.5, CH 8.26, d (2.3) H-7 C-4, 7, 8a
6 119.6, C -
7 136.4, CH 8.04, dd (8.7, 2.3) H-5, 8 C-5, 8a
8 118.5, CH 7.07, d (8.7) H-7 C-4a, 6, 8
8a 162.9, C -
9 21.2, CH3 1.30, s - C-2, 3, 10 H-3α (str), H3β (w), H-5, 8 (w)
10 66.8, CH2 3.49, dd (11.6, 4.5) OH-10
3.59, dd (11.6, 4.2)
11 166.4, CO -
OH-10 - 5.26, brt (5.4) -
OH-11 - 12.69, br -
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Figure 17. ORTEP di f compound 7.
In order to establish the conformation of the 2,3-dihydro-4H-pyran-4-one, analysis of the NOESY
correlations was carried out. The NOESY spectrum (Table 7, Figure 16b, Supplementary Information,
Figure S52) exhibited not only a strong correlation of H-7 to H-8, but also week correlations of H3-9
to H-5 and H-8. Therefore, CH3-9 is in the α-axial p sition. Additi nally, since H3-9 also exhibited
a strong cross-peak with the signal of the methylene proton at δH 2.74, d (J = 16.7 Hz), and a weak
cross-peak with the proton signal at δH 3.00, d (J = 16.7 Hz), the former was assigned to H-3α and
the latter to H-3β. It is interesting to observe that the structure of compound 7 is analogous to the
structure of compound 3 in that it also exhibits the same methyl-methylene bridge structural feature
(at C-9 and C-3), with the same relative intensity of NOESY cross-peaks between the protons of the
two groups and with similar conformational energies for the two half-chair conformations of the
non-aromatic ring. Therefore, the conclusions drawn for compound 3 are also valid for compound 7,
whose stereochemistry is unequivocally defined by X-ray analysis.
Compounds 1 and 5 can be hypothesized as originating from the pentaketide intermediate (I).
Methylation (by SAM) gives II, which undergoes cyclization and enolization to give the intermediate
III. Methylation of the phenolic hydroxyl groups and the α-carbon of the carbonyl ketone leads to the
intermediate IV. Enolization, followed by a lactonization, originates V, which undergoes hydration to
give VI, and oxidation of one of the methyl groups gives rise to compound 5. Alternatively, oxidation
of the α-carbon of the side chain of IV leads to the intermediate VII, which, after lactonization and
reduction of the ketone carbonyl, gives rise to compound 1 (Figure 18).
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cyclization via Route b leads to the formation of the pyran ring in XIV. Dehydration and oxidation of 
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function of the side chain will originate compound 2b. Alternatively, the intermediate XIV can also 
undergo dehydration, reduction and oxidation to give the ketone function in compound 7. Oxidative 
decarboxylation of compound 7 leads to the formation of compound 4a, which after sulfinylation of 
the benzene ring originates compound 4b. However, it is possible that the introduction of the methyl 
sulfoxide group to the aromatic ring could happen before cyclization. 
Figure 18. Proposed biosynthetic pathways for compounds 1 and 5.
Biosynthetically, compounds 2a, 2b, 4a, 4b, 6a, 6b and 7 are of mixed origin, i.e., shikimic acid
and mevalonic acid pathways, similar to that proposed for fomannoxin [19], as depicted in Figure 19.
Elimination of pyruvate from chorismate (IX) by chorismate pyruvate lyase leads to the formation of
p-hydroxybenzoic acid (X), which after prenylation by DMAPP (XI), originates the intermediate XII.
Epoxidation and cyclization of XII, via Route a, leads to a formation of the furan ring in compound
6a and after oxidation of one of the methyl groups leads to compound 6b. On the other hand,
cyclization via Route b leads to the formation of the pyran ring in XIV. Dehydration and oxidation
of one of the methyl groups originates compound 2a, which after acetylation of the primary alcohol
function of the side chain will originate compound 2b. Alternatively, the intermediate XIV can also
undergo dehydration, reduction and oxidation to give the ketone function in compound 7. Oxidative
decarboxylation of compound 7 leads to the formation of compound 4a, which after sulfinylation of
the benzene ring originates compound 4b. However, it is possible that the introduction of the methyl
sulfoxide group to the aromatic ring could happen before cyclization.
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Figure 19. Prop sed biosynthetic path f pounds 2a, 2b, 4a, 4b, 6a, 6b and 7.
Compound 3 is also derived from a prenylation of p-hydroxybenzoic acid (X); however, it can
occur with IPP (XVI) instead of DMAPP (XI). Epoxidation of the double bond of the side chain of
XVII, followed by cyclization of XVIII leads to the formation of an oxepin ring in XIX. Oxidation and
dehydration of the oxepin ring will lead to the formation of compound 3, as depicted in Figure 20.
Compounds 1–7 were evaluated for their antibacterial activity against Gram-positive and
Gram-negative bacteria, as well as multidrug-resistant isolates from the environment, according
to the previously described protocol [6], as well as for their antifungal activity against yeast
(Candida albicans ATCC 10231), filamentous fungus (Aspergillus fumigatus ATCC 46645) and
dermatophyte (Trichophyton rubrum FF5) in the antifungal assay [20]. The results showed that none of
the tested compounds exhibited significant antibacterial activity (MIC > 256 µg/mL) or antifungal
activity (MIC > 512 µg/mL). These compounds were also evaluated for their in vitro growth inhibitory
activity against the MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer) and
A375-C5 (melanoma) cell lines by the protein binding dye SRB method [21], and they did not show
any activity in this assay (GI50 > 150 mM).
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3. Experimental Section
3.1. General Procedure
Melting points were determined on a Bock monoscope and are uncorrected. Optical rotations
were measured on an ADP410 Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent,
U.K.). Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet iS10 from
Thermo Scientific (Waltham, MA, USA) with the Smart OMNI-Transmission accessory (Software
188 OMNIC 8.3). UV spectra were taken in CHCl3 and were recorded on a Varian CARY 100
spectrophotometer. 1H and 13C NMR spectra were recorded at ambient temperature on a Bruker
AMC instrument (Bruker Biosciences Corporation, Billerica, MA, USA) operating at 300.13 and
75.4 MHz, respectively. High resolution mass spectra were measured with a Waters Xevo QToF
mass spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Acquity UPLC
system. A Merck (Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck Si
gel 60 (0.2–0.5 mm) was used for column chromatography.
3.2. Extraction and Isolation
The strain KUFA 0081 was isolated fr m the marine s onge Clathria reinwardti, whic was
collected, by scuba diving at a depth of 15–20 m, fro the coral reef at Samae San Island
(12˝341 36.64” N 100˝561 59.69” E) in the Gulf of Thailand, Chonburi Province, in July 2013. The sponge
was washed with 0.06% sodium hypochlorite solution for 1 min, f llowed by sterilized seawater 3 times
and then dried on sterile filter p per, cut into small pieces (5 ˆ 5 mm) and placed on a malt extract
agar (MEA) edium containing 70% seawater and 300 mg/L of strept mycin sul hate, then incubated
at 28 ˝C for 7 days, after which the hyphal tips were transferred onto a slant MEA and maintained as
pure culture for further identification. The fungus was identified as Neosartorya quadricincta (E. Yuill)
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Malloch & Cain by one of us (T.D.), based on morphological characteristics, such as colony growth rate
and growth pattern on standard media, namely Czapek’s agar, Czapek yeast autolysate agar and malt
extract agar. Microscopic characteristics, including size, shape and the ornamentation of ascospores,
were examined under light and scanning electron microscopes. This identification was supported by
sequence analysis of the β-tubulin, calmodulin and actin genes as described in the previous report [22].
Neosartorya quadricincta was also confirmed by the analysis sequence of the internal transcribed spacer
(ITS) gene according the procedure previously described by us [7]. Its gene sequences were deposited
in GenBank with Accession Numbers KM095492 and KT201525, respectively. The pure cultures were
deposited as KUFA0081 at Kasetsart University Fungal Collection, Department of Plant Pathology,
Faculty of Agriculture, Kasetsart University, Bangkok, Thailand.
The fungus was cultured for one week at 28 ˝C in 10 Petri dishes (i.d. 90 mm) containing 25 mL
of MEA. In order to obtain the mycelial suspension, the mycelial plugs were transferred to two 500-mL
Erlenmeyer flasks containing 200 mL of potato dextrose broth and then incubated on a rotary shaker
at 120 rpm at 28 ˝C for 4 days. Fifty 1000-mL Erlenmeyer flasks, each containing 300 g of cooked
rice, were autoclaved at 121 ˝C for 15 min, then inoculated with 20 mL of mycelial suspension of
N. quadricincta and incubated at 28 ˝C for 30 days, after which the mouldy rice was macerated in
ethyl acetate (25 L total) for 7 days and then filtered. The ethyl acetate solution was concentrated
under reduced pressure to yield 176.5 g of crude ethyl acetate extract, which was dissolved in 500 mL
of CHCl3 and then washed with H2O (3 ˆ 500 mL). The organic layers were combined and dried
with anhydrous Na2SO4, filtered and evaporated under reduced pressure to give 31.1 g of the crude
chloroform extract, which was applied on a column of silica gel (440 g) and eluted with mixtures of
petrol-CHCl3 and CHCl3-Me2CO; 250-mL fractions were collected as follows: Frs 1–15 (petrol-CHCl3,
1:1), 16–55 (petrol-CHCl3, 3:7), 56–118 (petrol-CHCl3, 1:9), 119–284 (CHCl3-Me2CO, 9:1), 285–329
(CHCl3-Me2CO, 7:1), 330–359 (CHCl3-Me2CO, 1:1). Frs 175–181 were combined (250 mg) and purified
by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3:2:0.01) to give 86.8 mg of 1 and 15.0 mg of 2b. Frs
182–197 were combined (565.1 mg) and purified by TLC (silica gel G254, CHCl3-Me2CO-HCO2H,
17:3:0.02) to give 35.1 mg of 1 and 14.3 mg of 2b. Frs 224–235 were combined (249.3 mg) and purified
by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 4:1:0.01) to give 11.4 mg of 4a [12]. Frs 236–285
were combined (1.2 g), applied over a column chromatography of silica gel (42 g) and eluted with
mixtures of petrol-CHCl3 and CHCl3-Me2CO, wherein 100-mL subfractions were collected as follows:
sfrs 1–17 (petrol-CHCl3, 1:9), 18–61 (CHCl3-Me2CO,9:1). Sfrs 24–33 were combined (423.4 mg) and
precipitated in a mixture of CHCl3 and Me2CO to give a white solid (46.2 mg), which was further
recrystallized in a mixture of CHCl3 and Me2CO to give 9.4 mg of white crystals of 6a, and the mother
liquor was purified by TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 9:1:0.01) to give 23.2 mg of 6a
and 4.9 mg of 2a. The mother liquor of sfrs 24–33 (133.0 mg) was purified by TLC (silica gel G254,
CHCl3-Me2CO-HCO2H, 7: 3:0.01) to give 41.1 mg of 2a and 12.4 mg of 3. Sfrs 34–39 were combined
(77.7 mg) and purified with TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3: 1:0.01) to give 7.9 mg
of 4b and 17.1 mg of 2a. Sfrs 40–61 were combined (496.4 mg) and purified by TLC (silica gel G254,
CHCl3-Me2CO-HCO2H, 4: 1:0.01) to give 22.7 mg of 5. Frs 307–315 were combined (291.0 mg), applied
over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1 mixture of CHCl3:
MeOH to give twelve 1-mL sub-fractions. Sfrs 9–12 were combined and purified by TLC (silica gel
G254, CHCl3-Me2CO-HCO2H, 3: 2:0.01) to give 13.4 mg of 6b and 9.4 mg of 7. Frs 316–359 were
combined (1.2 g), applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with
a 1:1 mixture of CHCl3: MeOH to give twenty-one 1-mL sub-fractions. Sfrs 12–21 were combined
(645.7 mg), applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1
mixture of CHCl3: MeOH to give sixteen 1-mL fractions. Ssfrs 5–16 were combined (597.5), applied
over a column chromatography of silica gel (15 g) and eluted with a mixture of petrol-CHCl3 and
CHCl3-Me2CO, wherein 100-mL fractions were collected as follows: frs 1–8 (petrol-CHCl3, 1:9), 9–28
(CHCl3-Me2CO, 9:1), 29–41 ((CHCl3-Me2CO, 7:3). Frs 17–18 were combined (47.4 mg) and purified by
TLC (silica gel G254, CHCl3-Me2CO-HCO2H, 3: 2:0.01) to give 20.8 mg of 6b.
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3.2.1. Quadricinctone A: 3-(1-Hydroxyethyl)-5,7-dimethoxy-3,4-dimethyl-2-benzofuran-1(3H)-one (1)
White crystals; mp 176–177 ˝C (petrol/CHCl3); rαs20D ´59˝ (c 0.05, CHCl3); UV (MeOH) λmax
(log ε) 233 (4.39), 260 (4.03), 298 (3.78) nm; IR (KBr) υmax 3455, 2981, 2490, 1723, 1612, 1596, 1499,
1467, 1432, 1228 cm´1; 1H and 13C NMR, see Table 1; HRESIMS m/z 267.1243 [M + H]+ (calculated for
C14H19O5, 267.1332).
3.2.2. Quadricinctapyran A: 2-(Hydroxymethyl)-2-methyl-2H-chromene-6-carboxylic acid (2a)
White crystals; mp 147–148 ˝C (CHCl3/Me2CO); rαs20D +30˝ (c 0.03, MeOH); UV (MeOH) λmax (log ε)
237 (4.61) nm; IR (KBr) υmax 3447, 2922, 2359, 2341, 1696, 1647, 1609, 1578, 1490, 143, 1301, 1267 cm´1;
1H and 13C NMR, see Table 2; HRESIMS m/z 221.0820 [M + H]+ (calculated for C12H13O4, 221.0814).
3.2.3. Quadricinctapyran B: 2-[(Acetyloxy)methyl]-2-methyl-2H-chromene-6-carboxylic acid (2b).
White solid; mp 118–119 ˝C (petrol/CHCl3); rαs20D +58˝ (c 0.07, CHCl3); UV (MeOH) λmax (log ε)
201 (4.13), 237 (4.47) nm; IR (KBr) υmax 3441, 2986, 2943, 1745, 1678, 1640, 1607, 1574, 1453, 1419, 1297,
1264, 1228 cm´1; 1H and 13C NMR, see Table 2; HRESIMS m/z 263.0971 [M + H]+ (calculated for
C14H15O5, 263.0919).
3.2.4. Quadricinctoxepine: 3-Hydroxy-3-methyl-2,3-dihydro-1-benzoxepine-7-carboxylic acid (3)
White solid; mp 189–191 ˝C (CHCl3/Me2CO); rαs20D +21˝ (c 0.07, MeOH); UV (MeOH) λmax (log ε)
234 (4.50) nm; IR (KBr) υmax 3404, 2921, 2359, 2342, 1701, 1606, 1574, 1497, 1384, 1297, 1259, 1117 cm´1;
1H and 13C NMR, see Table 3; HRESIMS m/z 221.0819 [M + H]+ (calculated for C12H13O4, 221.0814).
3.2.5. Quadricinctone B: 6-Hydroxy-2,2-dimethyl-8-(methylsulfinyl)-2,3-dihydro-4H-chromen-4-one (4b)
White crystals; mp 227–228 ˝C (CHCl3/Me2CO); rαs20D +30˝ (c 0.03, MeOH); UV (MeOH) λmax
(log ε) 205 (4.27), 234 (4.22), 358 (3.64) nm; IR (KBr) υmax 3442, 2975, 2922, 1690, 1622, 1484, 1441, 1417,
1326, 1251, 1177 cm´1; 1H and 13C NMR, see Table 4; HRESIMS m/z 255.0694 [M + H]+ (calculated for
C12H15O4S, 255.0691).
3.2.6. Quadricinctone C: 3,6,8-Trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3,4-dihydro-1H
-isochromen-1-one (5)
White crystals; mp 223–224 ˝C (CHCl3/Me2CO); rαs20D +64˝ (c 0.06, MeOH); UV (MeOH) λmax
(log ε) 214 (4.23), 271 (3.96), 312 (3.70) nm; IR (KBr) υmax 3439, 3006, 2976, 2360, 2342, 1660, 1644, 1600,
1494, 1472, 1448, 1385, 1157 cm´1; 1H and 13C NMR, see Table 5; HRESIMS m/z 255.0875 [M + H]+
(calculated for C12H15O6, 255.0869).
3.2.7. Quadricinctafuran A: (2R)-(2-Hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid (6a)
White crystals; mp 149–150 ˝C (CHCl3/Me2CO); rαs20D +74˝ (c 0.03, MeOH); UV (MeOH) λmax (log
ε) 203 (3.40), 254 (3.49) nm; IR (KBr) υmax 3417, 2920, 1681, 1634, 1491, 1261 cm´1; 1H and 13C NMR,
see Table 6; HRESIMS m/z 223.9067[M + H]+ (calculated for C12H15O4, 223.0970).
3.2.8. Quadricinctafuran B: (2R)-2-(1,2-Hihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic
acid (6b)
White solid; mp 209–210 ˝C (CHCl3/Me2CO); rαs20D +20˝ (c 0.05, MeOH); UV (MeOH) λmax (log ε)
205 (4.27), 261 (4.03) nm; IR (KBr) υmax 3328, 2984, 2941, 1673, 1610, 1599, 1495, 1362, 1290, 1247 cm´1;
1H and 13C NMR, see Table 6; HRESIMS m/z 239.0919[M + H]+ (calculated for C12H15O5, 239.0919).
3.2.9. Quadricinctone D: 7-Hydroxy-3-(hydroxymethyl)-3-methyl-3,4-dihydro-2-benzoxepine-1, 5-dione (7)
White crystals; mp 196–197 ˝C (CHCl3/Me2CO); rαs20D +19˝ (c 0.05, MeOH); UV (MeOH) λmax
(log ε) 232 (4.21), 254 (3.84) nm; IR (KBr) υmax 3404, 2934, 2360, 2341, 1708, 1670, 1614, 1492,
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1466, 1250 cm´1; 1H and 13C NMR, see Table 7; HRESIMS m/z 237.0792 [M + H]+ (calculated for
C12H15O5, 237.0763).
3.3. X-Ray Crystal Structure of Compounds 1, 2a, 4b, 5, 6a and 7
Diffraction data were collected at 293 K with a Gemini PX Ultra equipped with CuKα radiation
(λ = 1.54184 Å). The structures were solved by direct methods using SHELXS-97 and refined with
SHELXL-97 [23]. Carbon, oxygen and sulphur atoms were refined anisotropically. Hydrogen atoms
were either placed at their idealized positions using appropriate HFIX instructions in SHELXL and
included in subsequent refinement cycles or were directly found from difference Fourier maps and
were refined freely with isotropic displacement parameters. Full details of the data collection and
refinement and tables of atomic coordinates, bond lengths and angles and torsion angles have been
deposited with the Cambridge Crystallographic Data Centre.
Quadricinctone A (1): Crystals were triclinic, space group P1, cell volume 663.27(7) Å3 and unit cell
dimensions a = 7.3973(5)Å, b =8.4830(6)Å and c = 11.2438(6) Å and angles α = 107.541(5)˝, β = 92.005(5)˝
and γ = 98.365(6)˝ (uncertainties in parentheses). The refinement converged to R (all data) = 3.68%
and wR2 (all data) = 9.54%. The absolute structure was established with confidence (flack x parameter
0.028(18)). CCDC 1465376.
Quadricinctapyran A (2a): Crystals were orthorhombic, space group Pbcn, cell volume 2189.45(9) Å3
and unit cell dimensions a = 21.3981(5)Å, b = 14.5017(3)Å and c = 7.05561(18)Å. The refinement
converged to R (all data) = 15.06% and wR2 (all data) = 40.39%. CCDC 1468869.
Quadricinctone B (4b): Crystals were orthorhombic, space group Iba2, cell volume 2469.66(11) Å3 and
unit cell dimensions a = 8.52510(19)Å, b = 30.2340(7)Å and c = 9.5817(3)Å. The refinement converged
to R (all data) = 5.90% and wR2 (all data) = 15.62%. The absolute structure was established with
confidence (flack x parameter ´0.04(4)). CCDC 1468868.
Quadricinctone C (5): Crystals were monoclinic, space group P21, cell volume 1116.25(5) Å3 and unit
cell dimensions a = 12.1131(3)Å, b = 7.0501(2)Å and c = 13.2091(3)Å and β = 98.291(2)˝. The refinement
converged to R (all data) = 6.85% and wR2 (all data) = 17.04%. CCDC 1468170.
Quadricinctafuran A (6a): Crystals were monoclinic, space group P21/n, cell volume 1066.67(10)Å3
and unit cell dimensions a = 11.6064(7)Å, b = 5.9593(2)Å and c = 15.8588(8)Å and β = 103.481(6)˝.
The refinement converged to R (all data) = 11.08% and wR2 (all data) = 24.01%. CCDC 1468171.
Quadricinctone D (7): Crystals were orthorhombic, space group Pca21, cell volume 1081.35(13) Å3 and
unit cell dimensions a = 19.5607(13)Å, b = 7.4646(5)Å and c = 7.4058(5)Å. The refinement converged to
R (all data) = 3.81% and wR2 (all data) = 8.57%. CCDC 1468166.
3.4. Molecular Mechanics Conformation Analysis of 3 and 7
Molecular simulations for Structures 3 and 7 were carried out in ChemBio3D Ultra 14
(Perkin-Elmer). Molecular mechanics energy minimizations used the MM2 and MMFF force fields with
the ChemBio3D most recent default parameters and implementation, adequate for small to medium
carbon-based models. Ab initio MP2/6-311G and semi-empirical PM3 molecular modelling was done
using CS GAMESS interfaced by ChemBio3D. The conformational search was done by stochastic,
dihedral driver and molecular dynamics methods. Around 60 conformations were stochastically
created and then minimized using the PM3, MMFF and PM3 methods. The resulting models were
then grouped under the resultant two seven-membered ring conformations (exemplified in Figure 8
for 3). A minimal energy for each model set was found by driving by 360˝ the dihedral angles of the
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single bonds that attach substituent groups to the rings. Molecular dynamics runs were also applied to
the models to confirm the convergence to a minimal energy conformation for each model set.
4. Conclusions
Although Ozoe et al. had first reported the isolation of an isocoumarin derivative from the
culture of the fungus N. quadricincta strain PF1223, using a GABA receptor ligand as a screening target,
the source of the fungus was not revealed. Therefore, this is the first report on the secondary metabolites
of the culture of a marine-derived N. quadricincta (KUFA 0081). Among the nine new isolated
compounds, two are polyketide derivatives, and seven are benzoic acid derivatives. The isolation of
these structurally-unique, but related, metabolites from this fungus has allowed us to propose the
biosynthetic pathways leading to these metabolites. Interestingly, the unprecedented structure of
quadricinctone B (4b), which possesses a methyl sulfinyl group in the benzopyran nucleus, reflects
the capacity of this marine-derived strain to introduce sulphur into the aromatic ring. Therefore, this
marine strain of N. quadricincta (KUFA 0081) can have potential for biotechnological transformation.
Even though the isolated metabolites did not exhibit either antifungal/antibacterial activities or growth
inhibitory activity against the three cancer cell lines in our assay protocols, it does not mean that
they are devoid of other interesting biological activities. Therefore, it is necessary to investigate these
metabolites in other target-based assay protocols.
Supplementary Materials: The supplementary materials are available online at www.mdpi.com/1660-3397/14/
7/134/s1.
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